Jessica Hagen
The partners will study the effectiveness of SpotitEarly's breath-based test for detecting early-stage breast cancer.
The company will trial its AI eye-tracking technology in Antarctica to simulate the harsh conditions of deep space missions.
The company will adapt space-tested health technologies for Earth, including post-operative recovery kits, civilian spaceflight medical systems and longevity medicine tools.
The company will use the funds to scale nationally, broaden partnerships with payers and health systems, and expand into new neurological condition areas.
Telehealth company Caregility, hybrid cancer care company Daymark Health and virtual care company AmplifyMD also garnered funding.
The company will use the funds to expand Dreem Health, scale nationwide and advance its FDA-cleared sleep apnea technology.
The Series D funding brings the company’s total raise to $275 million and its valuation to more than $1 billion.
The integrated platform will combine patient engagement, care access, provider data management, price transparency and payment tools.
The company stated Capital Rx will still operate as its pharmacy benefits manager brand under Judi Health.
At Healthcare 2030 in Washington, D.C., panelists highlighted debated challenges around interoperability, FHIR adoption and the need for industry-wide standards.